Previous Article | Next Article 
Antimicrob Agents Chemother. 1992 July; 36(7): 1577-1579
Stability of meropenem and effect of 1 beta-methyl substitution on its stability in the presence of renal dehydropeptidase I.
M Fukasawa,
Y Sumita,
E T Harabe,
T Tanio,
H Nouda,
T Kohzuki,
T Okuda,
H Matsumura and
M Sunagawa
Research Laboratories, Sumitomo Pharmaceuticals Co., Ltd., Osaka, Japan.
ABSTRACT
The stability of meropenem in the presence of renal dehydropeptidase I (DHP-I) varied extremely with the animal source of the enzyme. Meropenem, compared with imipenem, was rather easily hydrolyzed by DHP-Is from mice, rabbits, and monkeys, while it showed a higher resistance to guinea pig and beagle dog DHP-Is. In addition, meropenem was four times more resistant than imipenem to human DHP-I. The 1 beta-methyl substituent on carbapenems, i.e., meropenem and 1 beta-methyl imipenem, made them considerably more resistant to mouse and swine DHP-Is than the 1-unsubstituted derivatives are.
Antimicrob Agents Chemother. 1992 July; 36(7): 1577-1579
This article has been cited by other articles:
-
Morinaga, Y., Yanagihara, K., Nakamura, S., Yamamoto, K., Izumikawa, K., Seki, M., Kakeya, H., Yamamoto, Y., Yamada, Y., Kohno, S., Kamihira, S.
(2008). In vivo efficacy and pharmacokinetics of tomopenem (CS-023), a novel carbapenem, against Pseudomonas aeruginosa in a murine chronic respiratory tract infection model. J Antimicrob Chemother
62: 1326-1331
[Abstract]
[Full Text]
-
Shibayama, T., Matsushita, Y., Kawai, K., Hirota, T., Ikeda, T., Kuwahara, S.
(2007). Pharmacokinetics and Disposition of CS-023 (RO4908463), a Novel Parenteral Carbapenem, in Animals. Antimicrob. Agents Chemother.
51: 257-263
[Abstract]
[Full Text]
-
Padilla, E., Alonso, D., Domenech-Sanchez, A., Gomez, C., Perez, J. L., Alberti, S., Borrell, N.
(2006). Effect of Porins and Plasmid-Mediated AmpC {beta}-Lactamases on the Efficacy of {beta}-Lactams in Rat Pneumonia Caused by Klebsiella pneumoniae.. Antimicrob. Agents Chemother.
50: 2258-2260
[Abstract]
[Full Text]
-
Ueda, Y., Kanazawa, K., Eguchi, K., Takemoto, K., Eriguchi, Y., Sunagawa, M.
(2005). In Vitro and In Vivo Antibacterial Activities of SM-216601, a New Broad-Spectrum Parenteral Carbapenem. Antimicrob. Agents Chemother.
49: 4185-4196
[Abstract]
[Full Text]
-
Robatel, C., Decosterd, L. A., Biollaz, J., Eckert, P., Schaller, M. D., Buclin, T.
(2003). Pharmacokinetics and Dosage Adaptation of Meropenem during Continuous Venovenous Hemodiafiltration in Critically Ill Patients. J Clin Pharmacol
43: 1329-1340
[Abstract]
[Full Text]
-
Ueda, Y., Sunagawa, M.
(2003). In Vitro and In Vivo Activities of Novel 2-(Thiazol-2-ylthio)-1{beta}-Methylcarbapenems with Potent Activities against Multiresistant Gram-Positive Bacteria. Antimicrob. Agents Chemother.
47: 2471-2480
[Abstract]
[Full Text]
-
Park, S. W., We, J. S., Kim, G. W., Choi, S. H., Park, H. S.
(2002). Stability of New Carbapenem DA-1131 to Renal Dipeptidase (Dehydropeptidase I). Antimicrob. Agents Chemother.
46: 575-577
[Abstract]
[Full Text]
-
Yang, Y., Testa, R. T., Bhachech, N., Rasmussen, B. A., Bush, K.
(1999). Biochemical Characterization of Novel Tetrahydrofuranyl 1beta -Methylcarbapenems: Stability to Hydrolysis by Renal Dehydropeptidases and Bacterial beta -Lactamases, Binding to Penicillin Binding Proteins, and Permeability Properties. Antimicrob. Agents Chemother.
43: 2904-2909
[Abstract]
[Full Text]
-
Krueger, W. A., Schroeder, T. H., Hutchison, M., Hoffmann, E., Dieterich, H.-J., Heininger, A., Erley, C., Wehrle, A., Unertl, K.
(1998). Pharmacokinetics of Meropenem in Critically Ill Patients with Acute Renal Failure Treated by Continuous Hemodiafiltration. Antimicrob. Agents Chemother.
42: 2421-2424
[Abstract]
[Full Text]
-
Yamaguchi, K., Domon, H., Miyazaki, S., Tateda, K., Ohno, A., Ishii, K., Matsumoto, T., Furuya, N.
(1998). In Vitro and In Vivo Antibacterial Activities of CS-834, a New Oral Carbapenem. Antimicrob. Agents Chemother.
42: 555-563
[Abstract]
[Full Text]